Keren Osman, MD
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:Cancer (Oncology), Hematology-Oncology
MD, Mount Sinai School of Medicine
Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Medical Oncology, Memorial Sloan-Kettering Cancer Center
- BMT CTN 1302: A Multicenter Phase II, Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma
Multiple Myeloma is a cancer of the blood that begins in the bone marrow, a cancer that is currently incurable and even interventions that work may stop working after some time. This recurrence of cancer is known as relapse. Allogeneic Stem Cell Transplantation (AS...